Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feiyang Ma

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
The Journal of Investigative Dermatology|April 17, 2021
IRAK2 Has a Critical Role in Promoting Feed-Forward Amplification of Epidermal Inflammatory ResponsesShuai Shao, Lam C Tsoi, William R Swindell, et al.
Blood Cancer Discovery|August 4, 2022
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed SideroblastsVera Adema, Feiyang Ma, Rashmi Kanagal-Shamanna, et al.
Science (New York, N.Y.)|February 16, 2023
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responsesMingyu He, Kate Roussak, Feiyang Ma, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple MyelomaNatthakan Thongon, Feiyang Ma, Pamela Lockyer, et al.
Leukemia|February 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemiaSamarpana Chakraborty, Claudia Morganti, Kimberly Zaldana, et al.
The Journal of Clinical Investigation|December 5, 2023
Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativaKelsey R van Straalen, Feiyang Ma, Pei-Suen Tsou, et al.
The Journal of Clinical Investigation|November 23, 2021
Cardiomyocytes disrupt pyrimidine biosynthesis in nonmyocytes to regulate heart repairShen Li, Tomohiro Yokota, Ping Wang, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Aberrant oxidative metabolism selects for <i>TET2</i> -deficient hematopoietic stem and progenitor cellsKatia E Niño, Vera Adema, Alyx E Gray, et al.
Nature Medicine|March 4, 2022
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapyIrene Ganan-Gomez, Hui Yang, Feiyang Ma, et al.
Nature Biotechnology|May 14, 2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture methodYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
The Journal of Investigative Dermatology|April 17, 2021
IRAK2 Has a Critical Role in Promoting Feed-Forward Amplification of Epidermal Inflammatory ResponsesShuai Shao, Lam C Tsoi, William R Swindell, et al.
Blood Cancer Discovery|August 4, 2022
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed SideroblastsVera Adema, Feiyang Ma, Rashmi Kanagal-Shamanna, et al.
Science (New York, N.Y.)|February 16, 2023
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responsesMingyu He, Kate Roussak, Feiyang Ma, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple MyelomaNatthakan Thongon, Feiyang Ma, Pamela Lockyer, et al.
Leukemia|February 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemiaSamarpana Chakraborty, Claudia Morganti, Kimberly Zaldana, et al.
The Journal of Clinical Investigation|December 5, 2023
Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativaKelsey R van Straalen, Feiyang Ma, Pei-Suen Tsou, et al.
The Journal of Clinical Investigation|November 23, 2021
Cardiomyocytes disrupt pyrimidine biosynthesis in nonmyocytes to regulate heart repairShen Li, Tomohiro Yokota, Ping Wang, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Aberrant oxidative metabolism selects for <i>TET2</i> -deficient hematopoietic stem and progenitor cellsKatia E Niño, Vera Adema, Alyx E Gray, et al.
Nature Medicine|March 4, 2022
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapyIrene Ganan-Gomez, Hui Yang, Feiyang Ma, et al.
Nature Biotechnology|May 14, 2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture methodYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Pageof 16